Restoring balance
to the immune system
Image courtesy NIH
We are developing innovative cell therapies to treat patients suffering from a dysregulated immune system, including severe COVID-19.
Restore balance to the immune system
Overcome Conventional Cell Therapy Limitations
Our SBI-101 enables sustained, controlled dosage of MSC-secreted therapeutic molecules that are unattainable by direct injection or intravenous infusion.
What We Do
Transform cell therapy treatment
Realize the Vast Therapeutic Promise of MSCs
We are developing novel therapeutics for acute indications characterized by systemic inflammation, including COVID-19.
What We Do
Recent News and Events
Join Our Team
We are actively recruiting top scientific and commercial talent to join us on our quest to restore balance to the immune system and transform cell therapy treatment.
